What is the level of liabilities of Eisai Co this year?
Eisai Co has a debt balance of 518.19 B JPY this year.
Eisai Co Liabilities 2024
Eisai Co Liabilities
518.19 B JPY
Ticker
4523.T
ISIN
JP3160400002
WKN
855526
In 2024, Eisai Co's total liabilities amounted to 518.19 B JPY, a 5.65% difference from the 490.49 B JPY total liabilities in the previous year.
Eisai Co Aktienanalyse
What does Eisai Co do?
Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Eisai Co's Liabilities
Eisai Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Eisai Co's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Eisai Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Eisai Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Eisai Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Eisai Co stock
What were the liabilities of Eisai Co compared to the previous year?
The liabilities of Eisai Co have increased by 5.65% increased compared to the previous year.
What are the consequences of high debt for investors of Eisai Co?
High liabilities can pose a risk for investors of Eisai Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Eisai Co?
Low liabilities mean that Eisai Co has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Eisai Co affect the company?
An increase in liabilities of Eisai Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Eisai Co affect the company?
A decrease in the liabilities of Eisai Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Eisai Co?
Some factors that can influence the liabilities of Eisai Co include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Eisai Co so important for investors?
The liabilities of Eisai Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Eisai Co take to modify the liabilities?
To change its liabilities, Eisai Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Eisai Co pay?
Over the past 12 months, Eisai Co paid a dividend of 160 JPY . This corresponds to a dividend yield of about 2.91 %. For the coming 12 months, Eisai Co is expected to pay a dividend of 160.96 JPY.
What is the dividend yield of Eisai Co?
The current dividend yield of Eisai Co is 2.91 %.
When does Eisai Co pay dividends?
Eisai Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of Eisai Co?
Eisai Co paid dividends every year for the past 23 years.
What is the dividend of Eisai Co?
For the upcoming 12 months, dividends amounting to 160.96 JPY are expected. This corresponds to a dividend yield of 2.93 %.
In which sector is Eisai Co located?
Eisai Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Eisai Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Eisai Co from 12/1/2024 amounting to 80 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did Eisai Co pay the last dividend?
The last dividend was paid out on 12/1/2024.
What was the dividend of Eisai Co in the year 2023?
In the year 2023, Eisai Co distributed 160 JPY as dividends.
In which currency does Eisai Co pay out the dividend?
The dividends of Eisai Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Eisai Co
Our stock analysis for Eisai Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eisai Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
